Back to News
Market Impact: 0.2
Arcutis Biotherapeutics (ARQT) Moves 11.2% Higher: Will This Strength Last?
Source: zacks.com
Analyst EstimatesMarket Technicals & FlowsHealthcare & BiotechInvestor Sentiment & Positioning
Arcutis Biotherapeutics (ARQT) recorded an outsized price move on above-average trading volume in the prior session. However, recent earnings-estimate revision trends are unfavorable and may limit the stock's ability to sustain further near-term gains.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.20
Ticker Sentiment
ARQT-0.30
More News
- Binance seeks to shore up confidence after record $6.3 billion heist
- Binance sees $3.64 billion in net outflows as withdrawals resume after massive hack
- Amgen (AMGN) Bets on MariTide to Crack $120 Billion Obesity Market
- BTIG cuts Acumen Pharmaceuticals stock price target to $1 on trial results
- Aehr Test Systems earnings on deck amid AI chip boom
- People Inc earnings up next after MGM deal collapse